Effectiveness of Self-monitoring and Treatment of Blood Pressure Following Stroke or Transient Ischaemic Attack (TEST-BP)
Stroke
About this trial
This is an interventional treatment trial for Stroke focused on measuring Blood pressure monitoring, self BP monitoring, self BP management
Eligibility Criteria
Inclusion Criteria:
- Patients aged =/> 18 years old with TIA or stroke of mild/moderate severity (NIHSS =<15) who require BP management and are able and willing to undertake self BP measurement and guided alterations in therapy.
Exclusion Criteria:
- Those with terminal illness with life expectancy less than six months including end staged condition e.g. end stage COPD
- Dementia or moderate to severe cognitive impairment
- Those not receiving or expected to start anti-hypertensive therapy
Sites / Locations
- University of East Anglia
Arms of the Study
Arm 1
Arm 2
Arm 3
Sham Comparator
Placebo Comparator
Active Comparator
Standard BP management
Self BP measurement and standard care
Self BP measurement and treatment
Participants will continue to receive routine measurement of BP and management of treatment from their General Practitioner (GP).
Participants in this group (Se-Mo) will be taught to use a validated British Hypertension Society (BHS) approved home BP monitor (with built in memory/printer) by the study nurse along with written information on the procedure and a copy of the BHS Home BP Monitoring DVD. Participants will be contacted before each recording week & arrangements will be made to deliver and demonstrate the use of self BP monitor by the study nurse. Home BP monitoring will be performed over a 7 day period 3 times during the 6 month follow-up and on each occasion the patient will be given a copy of the BP results and asked to inform the GP of the results and the GP will decide if any alteration in therapy is needed.
Participants in this group will undergo exactly the same self BP monitoring training process as the Se-MO group and will undertake monitoring at the same time intervals. However they will be equipped with a validated BP monitor with a Bluetooth interface phone, BP values recorded by the patient will be transmitted automatically via mobile telephone to the trial coordinating centre. The data will be password protected and saved on a secure server and be available only to the trial team (study nurse & supervising physicians). The patient would then be contacted by the study nurse and depending on BP levels recorded the patient will alter their medication to achieve target BP levels. This will be recorded on the CRF and the GP notified of any treatment changes.